Recommendations from the American Headache Society
The American Headache society (AHS) provides clinicians with information and recommendations on new treatments for migraine. In 2021 the AHS has published an official consensus statement update on integrating new migraine treatments into clinical practice. The updated guideline included the following recommendations for use of neuromodulation devices including Nerivio:
“Consider neuromodulator devices in patients who prefer nondrug treatments, or in whom drug treatment is ineffective, intolerable, or contraindicated”
Source: Ailani J, Burch RC, Robbins MS, Board of Directors of the American Headache Society. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache,. Published online June 23, 2021. doi:10.1111/head.14153
